Advertisement

Pain pp 255-260 | Cite as

Neuroleptics (Typical/Atypical Antipsychotics)

  • Greta NemergutEmail author
  • Jennifer Sandra
Chapter

Abstract

Neuroleptics, or antipsychotics, have limited use in the treatment of pain. Only first generation, or typical antipsychotics, have been evaluated for use in some pain syndromes, with mixed results; second generation, or atypical antipsychotics, have only been primarily looked at in case studies. Antipsychotics work at a variety of receptors, including dopamine, serotonin, alpha adrenergic, muscarinic and histamine receptors. Their antagonist activity at the dopamine and serotonin receptors is thought to contribute to their effects on pain control. Antipsychotics have significant and varying side effects and are not recommended for initial or early treatment of pain.

Keywords

Neuroleptic Antipsychotic Typical Atypical Pain Fibromyalgia Receptors 

References

  1. 1.
    Aigner SS, Ossege M, Pernicka E, Wildner B, Sycha T. Antipsychotics for acute and chronic pain in adults (review). Cochrane Database Syst Rev. 2013;8:CD004844.Google Scholar
  2. 2.
    Khouzam HR. Psychopharmacotherapy of chronic pain: a focus on antidepressants and atypical antipsychotics. Postgrad Med. 2016;128(3):323–30.CrossRefGoogle Scholar
  3. 3.
    Facts and Comparisons eAnswers. First-generation (typical) antipsychotics. http://fco.factsandcomparisons.com/lco/action/doc/retrieve/docid/fc_dfc/5546134. Accessed Sept 2017.
  4. 4.
    Facts and Comparison eAnswers. Second-generation antipsychotics (atypical). http://fco.factsandcomparisons.com/lco/action/doc/retrieve/docid/fc_dfc/5546135. Accessed Sept 2017.
  5. 5.
    Walitt B, Klose P, Uceyler N, Phillips T, Hauser W. Antipsychotics for fibromyalgia in adults (review). Cochrane Database Syst Rev. 2016;6:CD011804.Google Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.UW Health, Pharmacy ServicesMadisonUSA

Personalised recommendations